Rigel Pharmaceuticals | RIGL - Ebit





Ebit Değişiklik Tarih
Agenus USD 15.05M 656K 2026-03
Amgen USD 4.68B 65M 2026-09
Anika Therapeutics USD 646K 3.88M 2025-12
Arrowhead Research USD -154.34M 13.08M 2026-06
AstraZeneca USD 4.66B 1.5B 2026-09
BioMarin Pharmaceutical USD 205.6M 100M 2026-09
Bristol-Myers Squibb USD 255M 44M 2026-09
Celldex Therapeutics USD -80.62M 3.81M 2026-06
Daiichi Sankyo JPY 108.7B 23.6B 2026-09
Eli Lilly USD 13.09B 635M 2026-09
Halozyme Therapeutics USD -60.68M 3.04M 2026-09
Heron Therapeutics USD 38K 3.83M 2025-12
Intrexon USD -26.3M 2.91M 2024-06
Ionis Pharmaceuticals USD -102.29M 15.71M 2026-06
Karyopharm Therapeutics USD -26.76M 8.92M 2026-03
Ligand Pharmaceuticals USD 54.53M 2.1M 2026-09
MacroGenics USD -65.25M 33.36M 2026-06
Neurocrine Biosciences USD 343M 123.1M 2026-09
Pfizer USD 4.85B 5.03B 2026-09
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Rigel Pharmaceuticals USD 447K 1.52M 2024-06
Ultragenyx Pharmaceutical USD -110M 35M 2026-09
Veracyte USD 18.02M 5.94M 2026-09